Protagonist Therapeutics, Inc. (PTGX)
82.76
-0.33
(-0.40%)
USD |
NASDAQ |
Feb 20, 16:00
82.77
+0.01
(+0.01%)
After-Hours: 20:00
Protagonist Therapeutics SG&A Expense (Quarterly) : 11.13M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Johnson & Johnson | 6.753B |
| ADMA Biologics, Inc. | 23.05M |
| Glaukos Corp. | 94.70M |
| Krystal Biotech, Inc. | 41.45M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |